HIGHLIGHTS
- who: Paweł Zapolnik and Antoni Pyrkosz from the University of Rzeszów, AlKopisto, a, Rzeszów, Poland have published the paper: RNF6 as an Oncogene and Potential Therapeutic Target—A Review, in the Journal: (JOURNAL)
- future: Such an agent primarily should be safe and effective so further research on RNF6 inhibitors is necessary. More research in this area is needed. More research is needed to assess the role of RNF6 and to check the safety and efficacy of inhibitors. Various authors performed the statistical analysis RNF6 and possible different RNF6 protein interactions at the cellular . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.